Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Tempus AI · with United Therapeutics · NCT06911632
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 900
- US sites recruiting
- 40
- Study start
- July 23, 2025
- Record last updated
- October 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Being studied: ECG-based AI Device - Results Returned to Investigator; Echocardiogram and Right Heart Catheterization; ECG-based AI Device - Results Not Returned to Investigator
Conditions: Pulmonary Hypertension; Interstitial Lung Disease (ILD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years or older at the time of consent
- A known diagnosis of interstitial lung disease
- Diffusing capacity for carbon monoxide (DLCO) \<30% predicted, collected within 6 months prior to consent
- Willing and able to provide informed consent and undergo all study-specific procedures, including echo and RHC, if required
Exclusion Criteria
- A known diagnosis of pulmonary hypertension (including patients prescribed a therapy specifically for pulmonary arterial hypertension (PAH))
- A RHC was completed within the previous 1 year or ordered and not yet completed at the time of consent
- LV ejection fraction ≤ 40% on most recent echo or cardiac MRI, if available
- Unclassifiable Tempus PH ECG risk result after up to 2 ECG acquisitions
- A contraindication to RHC exists (for example, pregnancy or mechanical right heart valve)
- Physician decision that if a patient is directed to RHC by the study protocol, the potential risks of RHC outweigh the potential benefits
- There is a severe concomitant illness limiting life expectancy to less than 6 months (at the discretion of the investigator)
- There is a medical or social factor that makes the patient a poor candidate for the study and/or unlikely to be able to comply with the study protocol or complete study procedures (at the discretion of the investigator)
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35205
Site contact: Andrea Ford · 205-0934-8904 · afcook@uabmc.edu
Banner University Medical Center
Phoenix, AZ 84006
Site contact: Clinical Research Coordinator · 602-521-6400 · slmarch@arizona.edu
Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute
Phoenix, AZ 85013
Site contact: Dominique Robertson · 602-406-1295 · dominique.robertson900@commonspirit.org
University of Arkansas
Little Rock, AR 72205
Site contact: Clinical Research Coordinator · 501-214-2407 · blee4@uams.edu
HCA Riverside Community Hospital
Riverside, CA 92501
Site contact: Alazzeh · 423-737-2281 · aalazzeh@pacificpulm.com
National Jewish Health
Denver, CO 80206
Site contact: Adrea Arthofer · 720-945-8608 · arthofera@NJHealth.org
AdventHealth Orlando
Orlando, FL 32803
Site contact: Kimberly Stark · 407-303-9984 · kimberly.stark@adventhealth.com
Northwestern University
Chicago, IL 60611
Site contact: Taryn Holt · 312-503-2157 · taryn.holt@northwestern.edu
University of Illinois Health
Chicago, IL 60612
Site contact: Dustin Fraidenburg, MD · 866-600-2273 · dfraiden@uic.edu
Indiana University Health Methodist Hospital
Indianapolis, IN 46202
Site contact: Isabell Mwaura · 317-274-0822 · imwaura@iu.edu
Community Health Network
Indianapolis, IN 46237
Site contact: Satish Krishnan, MD
University of Kentucky
Lexington, KY 40536
Site contact: Srushan Bhaktula · 859-323-5000 · ssh486@uky.edu
Willis Knighton Health
Bossier City, LA 71111
Site contact: Briana Barrow · bbarrow@wkhs.com
Louisiana State University Health Shreveport
Shreveport, LA 71102
Site contact: Teresa Leeth · 318-675-5920 · teresa.leeth@lsuhs.edu
Brigham and Women's Hospital
Boston, MA 02115
Site contact: Clinical Research Coordinator · 970-846-2343 · eharris@bwh.harvard.edu
University of Michigan - Michigan Medicine
Ann Arbor, MI 48109-5360
Site contact: Catherine Crombez · 734-232-4176 · cathercr@med.umich.edu
Corewell Health
Royal Oak, MI 48073
Site contact: Bobbie Lewis · 248-551-5958 · bobbie.lewis@corewellhealth.org
University of Minnesota
Minneapolis, MN 55455
Site contact: Mandi DeGrote · 612-626-7609 · carl1032@umn.edu
University of Mississippi Medical Center
Jackson, MS 39216
Site contact: Jaime Brown · jlbrown@umc.edu
Hannibal Regional Healthcare System
Hannibal, MO 63401
Site contact: 573-629-3926 · humam.farah@hannibalclinic.com
Mercy Hospital Springfield
Springfield, MO 65804
Site contact: Tracey Haertling · 508-264-5456 · nathan.frans@mercy.net
CHI Health Creighton University Medical Center - Bergan Mercy
Omaha, NE 68124
Site contact: Chloe Andersen · 402-343-8511 · chloe.andersen900@commonspirit.org
Renown Regional Medical Center
Reno, NV 89502
Site contact: Merlino · 775-982-7878 · amanda.merlino@renown.org
University of New Mexico
Albuquerque, NM 87131
Site contact: Goodale · 505-272-6794 · LGoodale@salud.unm.edu
University of Buffalo
Buffalo, NY 14203
Site contact: Kristopher Clark, MD
Weill Cornell University Medical College
New York, NY 10021
Site contact: Kimberly Kerr · 646-962-2333 · kke4001@med.cornell.edu
Southeastern Research Center
Winston-Salem, NC 27103
Site contact: Lauren Miller · 336-659-8414 · lmiller@southeasternresearchcenter.com
University Hospitals Cleveland Medical Center
Cleveland, OH 44121
Site contact: Jennie Pexa · 216-844-3201 · jennie.pexa@uhhospitals.org
University of Oklahoma
Oklahoma City, OK 73104
Site contact: Maria Mason · 405-271-6173 · Maria-l-mason@ouhsc.edu
Thomas Jefferson University
Philadelphia, PA 19107
Site contact: Mallem · 215-955-9181 · djamila.mallem@jefferson.edu
Temple University of The Commonwealth System of Higher Education
Philadelphia, PA 19140
Site contact: Kimberly Selwood · 215-707-2291 · Kim.Selwood@tuhs.temple.edu
Medical University of South Carolina
Charleston, SC 29425
Site contact: Krishna · 843-792-1794 · georgjam@musc.edu
University of Tennessee
Knoxville, TN 37920
Site contact: Herbert · 865-305-4893 · bherbert@utmck.edu
Baylor University Medical Center
Dallas, TX 75246
Site contact: Brianna Kamran · 214-820-6856 · Brianna.Kamran@bswhealth.org
Baylor College of Medicine
Houston, TX 77030
Site contact: Ivan Rosas, MD
Houston Methodist Hospital
Houston, TX 77030
Site contact: Rosa De Costa · 713-441-7182 · zsafdar@houstonmethodist.org
HCA Research Institute - Methodist Hospital
San Antonio, TX 78229
Site contact: Clinical Research Coordinator · 210-575-9500 · samantha.guerra@hcahealthcare.com
University of Utah
Salt Lake City, UT 84103
Site contact: Stefanos Lakonios · 801-581-5811 · stefan.lakonios@hsc.utah.edu
Virginia Commonwealth University
Richmond, VA 23298
Site contact: Robin Toft · 804-628-4570 · robin.toft@vcuhealth.org
West Virginia University Hospital
Morgantown, WV 26505
Site contact: Chad Glaze · 304-293-4661 · cglaze@hsc.wvu.edu
Study contacts (from the official record)
- Momentous Study · (833) 514-4187 · momentous-study@tempus.com
Similar studies in Alabama
All heart & blood pressure studies in Alabama →- RecruitingHealthy volunteersPhase 1
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
University of Alabama at Birmingham
- Location
- Birmingham, AL
- Eligibility basics
- Ages 14–89 · Women only
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Birmingham, AL + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Merck Sharp & Dohme LLC
- Location
- Alexander City, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 18+